Association between the response of intravitreal antivascular endothelial growth factor injection and systemic factors of diabetic macular edema

Table 2 Comparison between complete response and incomplete response

Parameters	Complete response(n = 51)	Incomplete response(n = 38)	p-value
DM duration, years	8.9 ± 6.6	9.5 ± 7.1	*0.511
insulin using, n(%)	15(29.4%)	12(31.6%)	†0.433
PreCMT, µ	452.6 ± 66.3	448.3 ± 61.1	*0.316
PreBCVA, logMAR	0.48 ± 0.21	0.52 ± 0.23	*0.273
albuminuria, n(%)	13(25.5%)	10(26.3%)	†0.631
BUN, mg/dL	24.7 ± 7.7	27.7 ± 9.1	*0.281
Creatinine, mg/dL	2.2 ± 0.9	2.4 ± 1.3	*0.236
eGFR, mL/min/1.7m²	27.8 ± 11.8	26.1 ± 12.8	*0.341
HbA1c, %	7.16 ± 2.31	7.30 ± 3.01	*0.221
Total cholesterol, mg/dL	145.5 ± 38.9	149.1 ± 41.8	*0.412

DM = diabetes mellitus, CMT = central macular thickness, BCVA = Best corrected visual acuity, logMAR = logarithm of the minimum angle of resolution, BUN = blood urea nitrogen, eGFR = estimated glomerular filtration rate, HbA1c = hemoglobin A1c, *Independent t-test, †X square test

ISSN: 1471-2415